Concourse Financial Group Securities’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 10196 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 10210 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 9853 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 9519 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 9295 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 9072 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 8842 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 8625 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 8303 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 8312 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 8140 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 7995 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 7822 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 7667 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 7380 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 7096 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 6823 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 6597 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6371 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6217 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6123 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 6036 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 5884 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 5895 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 5789 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 5705 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 5549 |
|